FDA allows 23andMe to sell genetic tests for 10 diseases The U.

FDA allows 23andMe to sell genetic tests for 10 diseases – The U.S. Contained in the list are Alpha-1 antitrypsin deficiency, a problem that boosts the chance of lung and liver disease, Point XI deficiency, a blood vessels clotting disorder, Gaucher disease type 1, an organ and tissues disorder, early-onset primary dystonia, a movement disorder, and different blood disorders. The FDA said 23andMe shall not be asked to submit additional tests for review ahead of being marketed. The special handles will become a benchmark for others developing similar tests also. The testing can’t be utilized to really detect disease. The virus, which will not pose a significant danger to the people, was detected among laying hens within a flock of 15,000 wild birds that were vaccinated and didn’t show any clinical signs of the condition, the Paris-based OIE said within a notification.Universal competition to Copaxone increases problems at Teva, which employed a new leader last month since it struggles with large debts and a squeeze in margins because of its own huge portfolio of common medicines.

Is vegetable oil really as good as a statin? Statin medicines have been the main topic of multiple gold-standard clinical studies involving plenty of patients. The study unequivocally demonstrates these medications lower the speed of heart episodes and strokes in people at risky of coronary disease. Various other researchers have viewed the data and concluded, just like the AHA, that fat molecules modification might drive back cardiovascular disease.